PVOD is rare cause of pulmonary artery hypertension which is associated with worse prognosis and limited treatment options apart from lung transplantation. Differentiating IPAH patients from PVOD is sometimes difficult relying on catheterization data alone. But differentiation between these two diseases is important as there are many evolved treatment options for IPAH. Here we are reporting a case of IPAH where catheterization data shows conflicting results which on further evaluation diagnosis confirmed as idiopathic pulmonary hypertension.
INTRODUCTION
Idiopathic pulmonary arterial hypertension (IPAH) is a rare disorder that can be defined as a sustained elevation in PAP and pulmonary vascular resistance, with normal pulmonary artery wedge pressure, in the absence of a known cause. It is diagnoses of exclusion after other possible causes of PAH have been excluded. It is a severe and often rapidly progressive illness in many cases. We are reporting a case of IPAH in a middle aged female who had features of pulmonary venous occlusive disease (PVOD).
CASE REPORT
A 35 year old women who is apparently normal 1month before presented with progressive dyspnea on exertion (NYHA class 2) ,facial puffiness ,bilateral pitting pedal edema ,abdomen distension since 2 wks. There is no history of syncope, chest pain, palpitations, abdomen pain or fever. There is no history suggestive of connective tissue disorders. Patient is married and had 2 children, last child with age of 14 yrs. On examination patient is not anemic. There was no rest or exertional cyanosis. Jugular venous pressure was elevated with Cardiac catheterization showed mild systemic hypertension (FA-140/70) elevated right ventricular and pulmonary artery systolic pressure (PA-66/21 with mean PAP-50, RV-66/0-2). Left ventricular pressure was normal (LV-110/0-7). Swann Ganz catheter is wedged in right lower pulmonary artery zone. Pulmonary capillary wedge pressure was elevated (PCWP-22). In the absence of left AV valve obstruction we suspected pulmonary venous obstruction in this patient. Saturation data did not reveal any shunt with systemic desaturation (FA So2 -75%, PA So2 -43.6%). We did CT pulmonary angiogram (CTPA) to rule out pulmonary thromboembolism and in venous phase to see for pulmonary venous obstruction. It showed evidence of PAH with cardiomegaly,no evidence of acute or chronic PTE. Venous phase study Images were obtained during a single breath hold at full inspiration, with the following parameters: collimation, 2.5 mm;
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DISCUSSION
Idiopathic pulmonary arterial hypertension is uncommon, representing only a tiny fraction of all cases of pulmonary arterial hypertension. Typically this entity is seen in young women, with diagnosis most frequently made between 20 and 30 years of age [1] .Idiopathic PAH is a progressive disorder that usually culminates in right ventricular failure and death. Indifferent small series of PAH studies, the estimated prevalence of PVOD among patients clinically diagnosed with idiopathic PAH varies from 5-20% [2] . An Estimate says that 6% of patients who clinically believed to have primary pulmonary hypertension may have evidence of PVOD at autopsy [3] . In this patient catheterization results favored PVOD. But the CTPA with venous phage imaging doesn't show any evidence of PVOD. Differentiating these two diseases is very important as the treatment and prognosis is different. PVOD is a clinico-pathologic entity characterized by occlusion or narrowing of the pulmonary veins and venules by sometimes loose, sometimes more dense and collagen-rich, fibrous tissue [4] leading to clinical manifestations that are, in many ways, similar to PAH.PVOD, being a post-capillary process, leads to increased visceral pleural and pulmonary capillary pressures with transudation of fluid into the pleural space resulting in pleural effusions. Pleural effusions are very rare in patients with primary pulmonary hypertension [5] . Chronic PTE, systolic /diastolic LV dysfunction, left AV valvular diseases, fibrosing mediastinitis, pulmonary capillary hemangiomatosis should be considered in the differential diagnosis of PVOD.
In catheterization test a PCWP of <15 mm Hg ((if catheter is properly wedged) and PVR of >3 WU, mean PA pressure of > 50mmhg goes in favor of PVOD. The central pulmonary veins and the left atrium are not enlarged, in contrast to patients with mitral stenosis, cortriatriatum, or left atrial myxoma [6] .The association of ill-defined nodules, septal thickening, and lymphadenopathy should raise the suggestion of a diagnosis of PVOD [7,8.] . Interestingly, a clue to the diagnosis of pulmonary veno-occlusive disease is the inability to accurately measure the wedge pressure during cardiac catheterization. Multiple wedge pressure measurements or a distal wedge reading confirmed by a partial pressure of oxygen similar to arterial blood should be performed to determine the correct wedge pressure. A correctly performed pulmonary capillary wedge pressure measurement generally reveals normal or decreased wedge pressure, despite the fact that the pulmonary capillary pressures (in the absence of a static blood column) are elevated. Occasionally, as in this case an elevated wedge pressure may be obtained, depending on the degree of venous occlusion and collaterals. This may occur because of the patency of the larger pulmonary veins [9] .so proper recording of PCWP in different positions will give the correct values. The development of pulmonary edema in response to a pulmonary vasodilator, therefore, is strongly suggestive of the diagnosis of PVOD [10] . A surgical lung biopsy in patients with suspected pulmonary veno-occlusive disease (PVOD) carries a serious risk of morbidity and mortality, particularly in the setting of high pulmonary vascular pressure [11] . Moreover, the results of the biopsy rarely affect PVOD treatment.
The prognosis in PVOD is bad. Most patients have a rapidly progressive course with most reported patients dying within two years of diagnosis without proper treatment [12, 13] . Currently available PAH therapies do not appear to have a profound effect on survival in patients with PVOD. Currently, lung transplantation is the only therapeutic option capable of significantly prolonging and improving the lives of patients with PVOD. So, correct diagnosis of the type of pulmonary arterial hypertension is mandatory for guiding the treatment protocol.
In our case there was elevated PCWP, but the PCWP in different wedge positions was not tried. As already mentioned previously not only we have to see the wedge trace to see whether that pressure display is due to proper wedging along with oxygen saturation estimation, which was not done in this case. This lead to further testing with chest CT scan.
